Core One Labs Inc. C.COOL

Alternate Symbol(s): CLABF

Healthcare Cannabis

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.

CSE:COOL - Post by User

Core One Labs Inc.

Bullboard Posts

Comment by cloreenbaconskinon Nov 17, 2016 10:22am

92 Views

Post# 25474551

RE:RE:Recreational Marijuana likely not for sale till Jan 2018

JUSTIFYING $3

The publicly traded Peers in Canada are trading at 17 times 2017 Revenue. Official California stats forecast 2017 MMJ revenue near $2.8 Billion. If LDS can capture 1% of that market, gross (high margin) revenue is U.S. $28 million or $37M Cdn.

In my valuation table, I used $6M U.S. for total 2017 revenue. If you multiply that by 17 (the average for the peers), and divide by the shares outstanding, it produces $3.33 per share.

The above is from his Oct 27th release - based on revenue from medical MJ only.